- US11767361utility2023Method of Treating Lung Cancer0 cites
- US11767364utility2023TL1A Antibodies and Methods of Treatment0 cites
- US11760763utility2023Heteroaryl Compounds Useful as MK2 Inhibitors0 cites
- US11760777utility2023Methods of Antibody Production That Minimize Disulfide Bond Reduction0 cites
- US11761951utility2023Methods of Selecting Therapeutic Molecules0 cites
- US11745165utility2023Supramolecular Filamentous Assemblies for Protein Purification0 cites
- US11739098utility2023Substituted Indole Compounds0 cites
- US11723975utility2023Compositions Comprising an Anti-lag-3 Antibody or an Anti-lag-3 Antibody and an Anti-pd-1 or Anti-pd-l1 Antibody0 cites
- US11718601utility2023Pyridinyl Substituted Oxoisoindoline Compounds0 cites
- US11713312utility2023Substituted Bicyclic Compounds as Farnesoid X Receptor Modulators0 cites
- US11713316utility2023Substituted Naphthyridinone Compounds Useful as T Cell Activators0 cites
- US11708327utility2023Phenylpyrrolidinone Formyl Peptide 2 Receptor Agonists0 cites
- US11701373utility2023Substituted Bicyclic Compounds0 cites
- US11697646utility2023Triazole N-linked Carbamoyl Cyclohexyl Acids as LPA Antagonists0 cites
- US11698358utility2023Method of Purity Determination by Capillary Electrophoresis0 cites
- US11685787utility2023Treatment of Cancer with Anti-gitr Agonist Antibodies0 cites
- US11672780utility2023[1,2,4]triazolo[1,5-a]pyridinyl Substituted Indole Compounds0 cites
- US11673886utility20235-membered and Bicyclic Heterocyclic Amides as Inhibitors of ROCK0 cites
- US11667663utility2023Cyclic Dinucleotides as Anticancer Agents0 cites
- US11660311utility2023Cyclic Dinucleotides as Anticancer Agents0 cites